NEPHROCARE HEALTH SERV L Latest Share Price (NEPHROPLUS)
TODAY IN ONE LINE
NEPHROPLUS slipped 0.5%, in line with Nifty's -1.1% move.
With a market cap of ₹6,124.04 Cr., it trades at a P/E of 79.50. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
NEPHROCARE HEALTH SERV L flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.01x
- ●FII AccumulationFII holding increased by 2.95% QoQ
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 88.6x
- ●Promoter SellingPromoter holding decreased by 3.26% QoQ
Latest NEPHROCARE HEALTH SERV L News
What changed recently?
Recent events, corporate actions, and announcements.
NEPHROCARE HEALTH SERV L valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for NEPHROCARE HEALTH SERV L, framed against the sector median so the premium or discount is obvious at a glance.
NEPHROCARE HEALTH SERV L trades at a P/E of 79.50× and P/B of 5.47×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
NEPHROCARE HEALTH SERV L technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for NEPHROCARE HEALTH SERV L — derived from the latest tape, not yesterday's close.
NEPHROCARE HEALTH SERV L last traded at ₹611.55 with an intraday range of ₹603.6–₹618.8 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹611.55| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 649.43 | +37.88 | +6.19% |
| R3 | 634.23 | +22.68 | +3.71% |
| R2 | 626.52 | +14.97 | +2.45% |
| R1 | 619.03 | +7.48 | +1.22% |
| PIVOT | 611.32 | -0.23 | -0.04% |
| CURRENT | 611.55 | — | — |
| S1 | 603.83 | -7.72 | -1.26% |
| S2 | 596.12 | -15.43 | -2.52% |
| S3 | 588.63 | -22.92 | -3.75% |
| S4 | 573.43 | -38.12 | -6.23% |
NEPHROPLUS is trading Above CPR, indicating Bullishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹609.45–₹618.8
Trading Inside opening range
NEPHROCARE HEALTH SERV L financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for NEPHROCARE HEALTH SERV L — consolidated or standalone — with margins, YoY growth and key ratios inline.
NEPHROCARE HEALTH SERV L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹6,124.04 Cr. and reported EPS of ₹3.19.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 999 | 999 ▲ 0.0% |
| Other Income | 25 | 25 ▲ 0.0% |
| Total Income | 1,023 | 1,023 ▲ 0.0% |
| 227 | 227 ▲ 0.0% | |
| Gross ProfitDerived | 772 | 772 ▲ 0.0% |
| Gross Margin %Derived | 77.29% | 77.29% |
| 545 | 545 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 227 | 227 ▲ 0.0% |
| OPM %Derived | 22.72% | 22.72% |
| 151 | 151 ▲ 0.0% | |
| Profit Before Tax (PBT) | 101 | 101 ▲ 0.0% |
| 21 | 21 ▲ 0.0% | |
| Effective Tax %Derived | 20.52% | 20.52% |
| Total Profit for Period | 77 | 77 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 77 | 77 ▲ 0.0% |
| Net Profit Margin %Derived | 7.69% | 7.69% |
| Earnings Per Share (EPS ₹) | 7.66 | 7.66 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 10 | 10 ▲ 0.0% |
| Share of Profit from Associates/JVs | -3 | -3 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 19 | 19 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 923 | 923 ▲ 0.0% |
| Material Cost % of RevenueDerived | 22.71% | 22.71% |
| Employee Cost % of RevenueDerived | 17.20% | 17.20% |
| Other Cost % of RevenueDerived | 37.37% | 37.37% |
| Interest Coverage (x)Derived | 2.26x | 2.26x |
| Period | Mar 2026 | May 2026 | Trend |
|---|---|---|---|
| Revenue from Operations | 999 | 999 ▲ 0.0% | |
| Other Income | 25 | 25 ▲ 0.0% | |
| Total Income | 1,023 | 1,023 ▲ 0.0% | |
227 | 227 ▲ 0.0% | ||
| Gross ProfitDerived | 772 | 772 ▲ 0.0% | |
| Gross Margin %Derived | 77.29% | 77.29% | |
545 | 545 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 227 | 227 ▲ 0.0% | |
| OPM %Derived | 22.72% | 22.72% | |
151 | 151 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 101 | 101 ▲ 0.0% | |
21 | 21 ▲ 0.0% | ||
| Effective Tax %Derived | 20.52% | 20.52% | |
| Total Profit for Period | 77 | 77 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 77 | 77 ▲ 0.0% | |
| Net Profit Margin %Derived | 7.69% | 7.69% | |
| Earnings Per Share (EPS ₹) | 7.66 | 7.66 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 10 | 10 ▲ 0.0% | |
| Share of Profit from Associates/JVs | -3 | -3 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 19 | 19 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 923 | 923 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 22.71% | 22.71% | |
| Employee Cost % of RevenueDerived | 17.20% | 17.20% | |
| Other Cost % of RevenueDerived | 37.37% | 37.37% | |
| Interest Coverage (x)Derived | 2.26x | 2.26x |
NEPHROCARE HEALTH SERV L segment analysis : revenue and profit mix.
Disclosed business segments at NEPHROCARE HEALTH SERV L with their share of revenue and profit, switchable between consolidated and standalone reporting.
NEPHROCARE HEALTH SERV L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for NEPHROCARE HEALTH SERV L.
Our AI distills the core fundamental drivers supporting NEPHROCARE HEALTH SERV L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 103 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
NEPHROCARE HEALTH SERV L peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — NEPHROCARE HEALTH SERV L is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
NEPHROCARE HEALTH SERV L chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for NEPHROCARE HEALTH SERV L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
NEPHROCARE HEALTH SERV L delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for NEPHROCARE HEALTH SERV L over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in NEPHROCARE HEALTH SERV L stood at 56.0% of traded volume, against a 20-day average of 57.6%.
NEPHROCARE HEALTH SERV L announcements: results, concalls, ratings, M&A.
Filings NEPHROCARE HEALTH SERV L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
NEPHROCARE HEALTH SERV L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 76 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Nephrocare Health Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Trading Window
Nephrocare Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)…
Analysts/Institutional Investor Meet/Con. Call Updates
Nephrocare Health Services Limited has informed the Exchange about Schedule of meet
Credit Rating- Revision
Nephrocare Health Services Limited has informed the Exchange about Credit Rating- Revision
Other Restructuring
Nephrocare Health Services Limited has informed the Exchange about Other Restructuring - Rationalisation and Consolidation of Company''s Step-down…
Investor decks & rating reports.
NEPHROCARE HEALTH SERV L dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue NEPHROCARE HEALTH SERV L has declared, sequenced by announce and record date.
NEPHROCARE HEALTH SERV L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About NEPHROCARE HEALTH SERV L: business, sector, key facts.
What NEPHROCARE HEALTH SERV L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
NEPHROCARE HEALTH SERV L is a listed Indian equity, listed as NSE: NEPHROPLUS, BSE: 544647.
NEPHROCARE HEALTH SERV L
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B BLACKBIO DX (3BBLACKBIO) Share PricePeer
- ABBOTT INDIA (ABBOTINDIA) Share PricePeer
- ACUTAAS CHEMICALS (ACUTAAS) Share PricePeer
- ANLON HEALTHCARE (AHCL) Share PricePeer
- AMANTA (AMANTA) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about NEPHROCARE HEALTH SERV L (NEPHROPLUS).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of NEPHROCARE HEALTH SERV L (NEPHROPLUS)?
The current share price of NEPHROCARE HEALTH SERV L (NEPHROPLUS) is ₹611.55. Today, the stock has declined by ₹2.80 (0.46%), trading in a range of ₹603.60 to ₹618.80. The stock opened at ₹612.00 with a trading volume of 1,52,507 shares.
02Is NEPHROCARE HEALTH SERV L stock a good investment for long-term?
NEPHROCARE HEALTH SERV L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹6,124.04 Cr., P/E ratio of 79.5, ROE of -0.83%, and ROCE of 5.17%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of NEPHROCARE HEALTH SERV L stock?
The 52-week high price of NEPHROCARE HEALTH SERV L (NEPHROPLUS) is ₹781.50, while the 52-week low is ₹446.00. Currently trading at ₹611.55, the stock is 37.12% above its 52-week low and 21.75% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy NEPHROCARE HEALTH SERV L stock at the current price?
Whether to buy NEPHROCARE HEALTH SERV L stock at ₹611.55 depends on multiple factors. The stock is currently trading with a P/E ratio of 79.5 and P/B ratio of 5.47. Today's performance shows a loss of 0.46%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of NEPHROCARE HEALTH SERV L and when is the next dividend?
NEPHROCARE HEALTH SERV L offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹611.55, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of NEPHROCARE HEALTH SERV L?
NEPHROCARE HEALTH SERV L's key financial metrics include: P/E Ratio: 79.5, P/B Ratio: 5.47, ROE: -0.83%, ROCE: 5.17%, Dividend Yield: 0%, EPS: ₹3.19, Book Value: ₹111.27, and Debt-to-Equity: 0.01. The company's market cap stands at ₹6,124.04 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is NEPHROCARE HEALTH SERV L stock performing today in the market?
NEPHROCARE HEALTH SERV L stock opened at ₹612.00 and is currently trading at ₹611.55, showing a decline of ₹2.80 (0.46%). The intraday high is ₹618.80 and low is ₹603.60. The trading volume stands at 1,52,507 shares, indicating moderate market participation today.
08What is the P/E ratio of NEPHROCARE HEALTH SERV L and what does it indicate?
NEPHROCARE HEALTH SERV L has a Price-to-Earnings (P/E) ratio of 79.5, which means investors are willing to pay 79.50 for every ₹1 of earnings. With an EPS of ₹3.19, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about NEPHROCARE HEALTH SERV L (NEPHROPLUS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.